|
|
 |
|
Viewing report
|
|
|
|
Lead Generation Strategies and Technologies in Drug Development - Emerging Techniques Such as Antisense Technology Will Allow Innovators to Minimize Costs
GBI Research, June 2011, Pages: 77
“Lead Generation Strategies and Technologies in Drug Development - Emerging Techniques Such as Antisense Technology Will Allow Innovators to Minimize Costs” provides key data, information and analysis of the major trends and developments in the drug devleopment business. The report provides a comprehensive insight into key technological developments, new approaches in lead generation and various technologies developed to accelerate it.The report also provides key alliances and collaborations in the industry to minimize costs and maximize productivity. This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by a team of industry experts.
Scope
The scope of the report includes:
- Key technological developments and new approaches including case studies.
- Case studies of new technologies and their implementation by companies in drug development industry
- Key drivers and restraints that have a significant impact on the market.
- Competitive benchmarking of leading CROs, covering their offerings and recent deals in drug development
Reasons to buy
The report will enhance your decision making capability. It will allow you to:
- Compare the key capabilities and models of major technology solution providers with your requirements and optimize your R&D costs
- Develop market entry and market expansion strategies by identifying the key drivers and challenges in the global drug development market
- Develop effective strategies to maximize the advantages through the understanding of drug development and business models.'
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
|
|
|
